Literature DB >> 22023209

Preparation and characterization of poly(2-hydroxyethyl methacrylateco- methyl methacrylate) hydrogels for sustained delivery of antitumor drug.

Madhu Babu D1, Satish C S, Ankur P Shah, Shivakumar H G.   

Abstract

The aim of this study was to prepare different types of cisplatin loaded poly(HEMA-co-MMA) hydrogel based implants. These systems are designed to release the drug in a time-controlled manner over several weeks which can help in optimizing the treatment of tumors. The prepared implants were evaluated for swellability, in vitro and in vivo release and biodegradation studies. Swelling studies of the implants were carried out in 7.4 pH phosphate buffer solution and swelling was to depend on the extent of cross-linking. From the results of in vitro release studies it was observed that, the diffusion coefficient of cisplatin in the early stages was in the range of 4.3× 10-6 to 8.0 ×10-6 cm2 min-1 and at later stages it was found to be in the range of 3.2 × 10-8 to 6.0 ×10-8 cm2 min-1. The results of the in vivo drug release revealed that the drug release was faster in vivo compared to the in vitro release for the corresponding formulations. The in vivo studies showed that cisplatin was released for a period of 20 days and also there was no fibrous capsule formation around the implant indicating the biocompatibility of the implant.

Entities:  

Year:  2011        PMID: 22023209

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  2 in total

1.  The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect.

Authors:  Farzaneh Ashrafi; Sara Haghshenas; Mehdi Nematbakhsh; Hamid Nasri; Ardeshir Talebi; Fatemeh Eshraghi-Jazi; Zahra Pezeshki; Tahereh Safari
Journal:  Int J Prev Med       Date:  2012-09

Review 2.  The roles of miRNAs as potential biomarkers in lung diseases.

Authors:  Shamila D Alipoor; Ian M Adcock; Johan Garssen; Esmaeil Mortaz; Mohammad Varahram; Mehdi Mirsaeidi; Aliakbar Velayati
Journal:  Eur J Pharmacol       Date:  2016-09-12       Impact factor: 4.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.